Findings underscore the liver safety of AD04 as compared to placebo in the prior Phase 3 clinical trial... Read this story
Findings underscore the liver safety of AD04 as compared to placebo in the prior Phase 3 clinical trial... Read this story
More from GlobeNewswire | Nasdaq:ADIL Adial Pharmaceuticals Inc Pharmaceutical industry Alcoholism Safety Clinical trial